HCW Biologics vs Tvardi Therapeutics
HCWB and TVRD side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HCWB and TVRD compare
Tvardi Therapeutics is the larger company, worth 9.4 times as much as HCW Biologics ($13.5M against $1.4M).
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HCWB | TVRD |
|---|---|---|
| Size and price | ||
| Market cap | $1.4M | $13.5M |
| Share price | $0.777 | $1.01 |
| Change, 1 year | −95.7% | −74.9% |
| Change, 5 years | −99.9% | −99.8% |
| Beta (5Y) | 2.48 | 2.82 |
| Employees | – | 12 |
| StockData Score | ||
| Total score | 6 | 6 |
| Valuation score | 3 (better) | 1 |
| Growth score | 2 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 0 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× | – |
| P/B | 0.2× (better) | 1.6× |
| Fair value | $15.10 | – |
| Margin of safety | 94.9% | – |
| Growth | ||
| Revenue growth (TTM) | 700% | – |
| Revenue growth, 5Y average | −57.9% | – |
| Profitability | ||
| Gross margin | 96.7% | – |
| Operating margin | −115% | – |
| Net margin | −83.8% | – |
| Return on equity | −151% | −126% (better) |
| Return on invested capital | −70.7% | – |
| Financial health | ||
| Debt / equity | 0.88 (better) | 0.00 |
| Interest coverage | −14.0× | – |
| Current ratio | 0.06 | 1.87 (better) |
| Altman Z-score | −7.21 (better) | −13.58 |
| Piotroski F-score | 2 (better) | 1 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 5.6% | 16.7% |
| Held by insiders | 34.9% | 15.6% |
| Insider net buying, 12 months | $532K | – |
| Short interest, % of float | 4.1% | 2.7% |
Go deeper
- HCWB stock overview
- HCWB income statement
- HCWB valuation and score
- TVRD stock overview
- TVRD income statement
- TVRD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.